Timely diagnosis and appropriate management of Peripheral Arterial Disease (PAD) are essential to improve outcomes, including reduced risk of amputation, cardiovascular events, and death, and improved physical function and quality of life.
BECTON DICKINSON
Company · Spain · EU Transparency Register 196359321438-80
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 925 companies & groups on this site, they rank #594 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- MedTech Europe →
- European Alliance for Access to Safe Medicines (EAASM)
- European Cancer Organization (ECO)
- Federation of European Academies of Medicine (FEAM)
- European Patient Safety Foundation (EUPSF)
- European Sepsis Alliance
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Companies & groups
- Registered as
- Becton Dickinson (BD)
- Head office
- New Jersey, Switzerland
- EU office
- Eysins
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track BECTON in PolicySpeak: request access →
Work at BECTON DICKINSON? so we know who speaks for it.
Their record over time
BECTON DICKINSON filed 1 position on 17 May 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from BECTON DICKINSON’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.